[The assessment of beta 2-microglobulin concentration in blood serum in patients with radiotherapy-treated laryngeal carcinoma].
The authors present estimation of beta 2-microglobulin concentration in blood serum in patients suffering from laryngeal cancer treated with radiotherapy in the course of treatment and 3 years after. The initial concentration of beta 2-microglobulin in the blood serum was statistically significantly higher in comparison with the control group. A significantly higher initial concentration of beta 2-microglobulin was observed in the group of patients with the recurrence of cancer in relation to the group of patients without the recurrence of cancer both immediately and 3 years after radiotherapy.
Debowska-Jarzebska
E
E
Instytut Medycyny Pracy i Zdrowia Srodowiskowego w Sosnowcu.
Pilch
J
J
Gierek
T
T
D000368:Aged; D000369:Aged, 80 and over; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy*; D006801:Humans; D007822:Laryngeal Neoplasms / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D012189:Retrospective Studies; D001613:beta 2-Microglobulin / Q000032:analysis*
D001613:beta 2-Microglobulin
Ocena stezenia beta 2-mikroglobuliny w surowicy krwi u chorych na raka krtani leczonych napromienianiem.